Testing the GeriKit app to better understand older adults with heart disease
Tests a mobile app to better understand older adults with heart disease.
Plain-language title generated from the registry record
Registry title: Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
Key facts
- Where
- New York, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 75 and 100 years old?
Source: NCT05788666, who can take part
Where in United States
- NYU Langone HealthNew York, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- NYU Langone Health
- Trial code
- NCT05788666
- Record updated
- 2 November 2026
- Original description
This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.Read full original descriptionShow less
Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.
Inclusion: Age ≥ 75; Currently hospitalized for acute mycardial infarction (AMI), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG); or hospitalized for AMI, PCI, or CABG within the prior 4 weeks; Capable of self-consent; Understand and are able to perform study procedures in English.
Exclusion: Moderate or severe cognitive impairment (operationalized as known diagnosis of dementia); Non-ambulatory; Unable or unwilling to consent; Incarcerated; Unable to use complete assessments in English; Unable to complete geriatric assessment for other reasons.